Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients? - Wikidata - wikimedia - TriplyDB

Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?

Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?

http://www.wikidata.org/entity/Q44055243

about

Significance of Anti-HLA Antibodies on Adult and Pediatric Heart Allograft Outcomes.Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation Human leukocyte antigens and alloimmunization in heart transplantation: an open debate.Acute Cellular Rejection and C4d Positivity in Heart Transplantation : A Manifestation of Asymptomatic Antibody-Mediated Rejection?The interplay of donor-specific antibodies, allograft C4d deposition, and antibody-mediated rejection.

P2860

Q37609092-88079ED4-A1E4-4A16-86E5-DD2767E3AA80 Q37616457-385B78B6-C666-46DF-BED6-156CB273A01C Q38246225-CCB32B4A-6616-4F19-8D6A-84AE8DC70606 Q40108113-506ECE12-EB9F-483E-86E5-50595A381096 Q44940147-6C7BDBBD-C815-4A17-82C7-4D5546510EEF

P2860

Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?

http://www.wikidata.org/entity/Q44055243

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?

@en

Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?

@nl

type

label

Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?

@en

Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?

@nl

prefLabel

Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?

@en

Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?

@nl

P1433

Q44055243-7534A19B-03C2-4E0D-93F7-B3ADEB1F52E0

P1476

Q44055243-0FDF0868-1ECA-463E-9FDA-53A616042C54

P2093

Q44055243-2F9FC563-1C91-44CB-9070-F09A1276761A

Q44055243-6A03070A-EB2E-47FE-B483-52F18E72A288

Q44055243-AC49236A-CBA6-4CB7-8C42-34946CEFF7F7

Q44055243-DD8F96CB-6D2B-441C-B5C2-677493B517D4

P2860

Q44055243-082FD255-D8D8-4B4C-86AE-5F67F07BCB71

Q44055243-162BED26-E46F-49E0-88B2-AB1102ED33CB

Q44055243-224BDD0B-2FE8-4371-BB56-FFBEAE0C92DA

Q44055243-22F4E471-754E-44BC-9823-263F65378C92

Q44055243-23414277-0F72-45FE-B100-1E920106CD9B

Q44055243-381D7767-B9EA-4F57-B4C5-5723239B85E4

Q44055243-3D705D9C-4CFB-41C0-82B2-15A4829745B7

Q44055243-443941F9-DE8E-459D-9B25-B71F24297B6B

Q44055243-5D1EA843-FF74-452C-9DE9-0F440E036B83

Q44055243-66B1103E-8A53-4271-8378-7AA97187588F

P304

Q44055243-EF3F7221-F0FB-4BDB-895B-1FC9F64A3748

P31

Q44055243-980D8F2E-3AF0-4E1D-9D66-0EFE6DD33638

P356

Q44055243-275DDF84-9DCA-4D21-BE4C-638887173CE4

P433

Q44055243-58BC4A67-6390-49A1-9A16-4BC229660FEE

P478

Q44055243-DC9D4452-EA1E-4C3D-8106-7F27671F999D

P50

Q44055243-2432D7A1-2723-4710-AF4A-0FE4ACC3EC97

Q44055243-E22175BB-0127-4790-8C95-7BFCC685B2A0

P577

Q44055243-0B19EC83-A02E-4652-80AF-3502E70BF956

P698

Q44055243-7235ABA1-EF35-48E7-983C-4CEEFF3EA342

P356

P1433

Pediatric Transplantation

P1476

Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?

@en

P2093

Karen Nelson

http://www.w3.org/2001/XMLSchema#string

Paul Warner

http://www.w3.org/2001/XMLSchema#string

Robert J Boucek

http://www.w3.org/2001/XMLSchema#string

Yuk M Law

http://www.w3.org/2001/XMLSchema#string

P2860

Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection.

Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection.

De novo production of antibodies after heart or lung transplantation should be regarded as an early warning system.

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.

Anti-HLA alloantibodies in pediatric solid organ transplantation.

Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns.

Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy.

Relevance of MICA and other non-HLA antibodies in clinical transplantation.

Report from a consensus conference on antibody-mediated rejection in heart transplantation

Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.

P304

429-435

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PETR.12075

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23551503

http://www.w3.org/2001/XMLSchema#string